INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2012

Aryl hydrocarbon receptor activation by dietary ligands supports intestinal immune cells and attenuates gut inflammation in animal models and human cells.

This review examines the role of the aryl hydrocarbon receptor (AhR) in intestinal immune homeostasis and inflammatory bowel disease. Activation of AhR by dietary ligands is required for maintaining innate immune cells such as intraepithelial lymphocytes and IL-22-producing lymphoid cells. In animal models, AhR activators inhibit proinflammatory cytokines and reduce colitis. In humans, intestinal T cells and natural killer cells from Crohn's disease patients express low AhR levels and respond to AhR ligands by reducing inflammatory cytokines and increasing IL-22.

Study type
Narrative review
Who was studied
Human Crohn's disease patients (isolated cells) and mice
What was measured
Intestinal immune homeostasis, mucosal inflammation, cytokine regulation

THE PAPER

The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis.

Monteleone I, MacDonald TT, Pallone F, Monteleone G. Curr Opin Gastroenterol, 2012.

PubMed 22450895 ↗DOI 10.1097/mog.0b013e328352ad69 ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.